These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 910990)

  • 21. The safety of a single daily dose schedule for imipramine.
    Saraf K; Klein DF
    Am J Psychiatry; 1971 Oct; 128(4):483-4. PubMed ID: 5098616
    [No Abstract]   [Full Text] [Related]  

  • 22. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypnopompic hallucinations and treatment with imipramine.
    Schlauch R
    Am J Psychiatry; 1979 Feb; 136(2):219-20. PubMed ID: 760554
    [No Abstract]   [Full Text] [Related]  

  • 24. Imipramine therapy and seizures: three children treated for hyperactive behavior disorders.
    Brown D; Winsberg BG; Bialer I; Press M
    Am J Psychiatry; 1973 Feb; 130(2):210-2. PubMed ID: 4685246
    [No Abstract]   [Full Text] [Related]  

  • 25. Slow constant intravenous infusion of imipramine up to 850 mgm/day in patients with affective illness.
    Crisp AH
    Curr Ther Res Clin Exp; 1966 Jan; 8(1):29-30. PubMed ID: 4955144
    [No Abstract]   [Full Text] [Related]  

  • 26. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 27. TCA-induced mania: differences between switchers and nonswitchers.
    Nasrallah HA; Lyskowksi J; Schroeder D
    Biol Psychiatry; 1982 Feb; 17(2):271-4. PubMed ID: 7074184
    [No Abstract]   [Full Text] [Related]  

  • 28. Mania following change from trazodone to imipramine.
    Haggerty JJ; Jackson R
    J Clin Psychopharmacol; 1985 Dec; 5(6):342-3. PubMed ID: 4067001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of depression with a single daily dose of imipramine pamoate.
    Mendels J; Digiacomo J
    Am J Psychiatry; 1973 Sep; 130(9):1022-4. PubMed ID: 4727758
    [No Abstract]   [Full Text] [Related]  

  • 30. [Depressions treated with imipramine-N-oxide and imipramine. A controlled double-blind trial].
    Ose E
    Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2388-94. PubMed ID: 4943561
    [No Abstract]   [Full Text] [Related]  

  • 31. [1st observations on the use of chlor-imipramine (G 34586) in a group of depressive patients].
    Robotti CA
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Jun; 92(3):939-48. PubMed ID: 5714909
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled double blind comparative study of single dose administration of imipramine pamoate and divided dose of imipramine hydrochloride in depressive illness.
    Khorana AB
    Indian J Physiol Pharmacol; 1981; 25(4):331-8. PubMed ID: 7042559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of activation/jitteriness associated with TCAs.
    Jackson CW; Lydiard RB
    J Clin Psychopharmacol; 1990 Dec; 10(6):439-40. PubMed ID: 2286716
    [No Abstract]   [Full Text] [Related]  

  • 35. Imipramine and seizures.
    Petti TA; Campbell M
    Am J Psychiatry; 1975 May; 132(5):538-40. PubMed ID: 804259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturalistic study of imipramine in panic disorder and agoraphobia.
    Aronson TA
    Am J Psychiatry; 1987 Aug; 144(8):1014-9. PubMed ID: 3300374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine dysfunction and blood levels of tricyclic antidepressants.
    de la Fuente JR; Rosenbaum AH
    Am J Psychiatry; 1980 Oct; 137(10):1260-1. PubMed ID: 7416280
    [No Abstract]   [Full Text] [Related]  

  • 38. Yohimbine and imipramine-induced orthostatia.
    Hyatt M; Messer M
    Am J Psychiatry; 1986 Mar; 143(3):389-90. PubMed ID: 3953875
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative safety of single versus divided dose imipramine in adolescent major depression.
    Ryan ND; Puig-Antich J; Cooper TB; Rabinovich H; Ambrosini P; Fried J; Davies M; Torres D; Suckow RF
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):400-6. PubMed ID: 3597296
    [No Abstract]   [Full Text] [Related]  

  • 40. Imipramine-induced hyperpigmentation: a case report and review of the literature.
    D'Agostino ML; Risser J; Robinson-Bostom L
    J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.